In a recent article in Today’s Clinical Lab, Newomics founder and CEO Daojing Wang discusses how microflow LC-MS is helping labs balance sensitivity, robustness, and throughput for applications such as hormone analysis, therapeutic drug monitoring, and metabolomics.
Read the ArticleToday’s Clinical Lab: Microflow LC-MS Gains Momentum in Clinical Laboratories
Posted on 03.18.26